Equity
€217,385 ▲ 2.4%
M10C paid out €27,536 in dividends. That is 85% of the 2025 profit.
M10C
Lifetime
11 annual accounts with figures on one time axispeak €64,265 (2024)
€44,097▼ 31.4%
peak €47,603 (2024)
€32,554▼ 31.6%
peak €217,385 (2025)
€217,385▲ 2.4%
€43,272▲ 8.4%
Board1 name since 2014
1 directorClaeys,Martine
Documentsfilings and deeds
28-08-202628 days late
2025micro format
Gross margin from €64,265 to €44,097Result from €47,603 to €32,554Dividend €27,536Cash from €80,634 to €47,268
Key points
from the 2025 annual accountsChecked score
94
Excellent
Financially stronger than 52% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: 0.1%▲ +0.1 percentage points vs 06-2025highest value
08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025lowest value
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 6.00, cash €47,268
Equity €217,385 (83.4% of total assets)
Figures for financial year 2025 (filed on 02-09-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 49% on liquidity, 34% on profitability and 42% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 34,693 companies had the same profile as M10C has now. Each dot stands for 87 companies, two years later.
95.3%
were still trading
3.9%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of M10C itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,693 companies, not a prediction for M10C. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €20,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 6.0 (6.28 in 2024), above the usual 1.5. Short-term debt is 16.6% and cash 18.1% of total assets. 16.6% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 28 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
28 days late
2024
14 days early
2023
55 days early
2022
17 days early
2021
89 days early
2020
on the day
2019
38 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 26 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0507797869
Change of role: CLAEYS Martine Marie Paule, from manager to director
enige aandeelhouder holds all the shares · Gazette deed
Incorporation
published on 31-12-2014 · Gazette deed
First establishment
Leeuwerikenlaan 20, De Haan
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| M10C De Haan | €260,657 | €44,097 | 83.4% | - |
| DE CLERCQ - DE BAERDEMAEKER Aalter | €175,307 | €43,010 | 85.4% | - |
| Blue Bridges De Haan | €392,459 | €81,848 | 35.8% | - |
| EU GLOBAL TRADE Berchem-Sainte-Agathe | €350,258 | €28,321 | 30.4% | - |
| BIOFIT Sint-Niklaas | €165,616 | €88,586 | 43.7% | 1.8 |
| DR. LOOSEN ERIK,HUISARTS Brussels | €121,595 | €10,930 | 94.2% | - |
| IasoD Stoumont | €274,840 | €183,968 | 88.3% | - |
These companies have the same main activity as M10C: other human health activities (NACE 86999). They are comparable in size and age: total assets between €122,000 and €392,000, founded between 1999 and 2023.
Official details
Source: KBO- Status
- Active since 29-12-2014Normal situation
- Activity
- Other human health activitiesNACE 86999and 2 others
- Establishment unit
- 2.238.313.2068420 De Haan, since 29-12-2014
- Financial year end
- 31 December
- Peppol
- Reachable since 30-01-2025
Insights on M10C
M10C files the micro format. That format states no turnover. The gross margin rose from €31,407 in 2015 to €44,097 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about M10C
- What is the company number of M10C?
- The company number of M10C is 0507.797.869. The VAT number is the same number with BE in front: BE 0507.797.869.
- Where is M10C based?
- The registered office is at Leeuwerikenlaan 20, 8420 De Haan.Company details
- What does M10C do?
- According to the KBO register, the main activity is other human health activities (NACE 86999).
- What is the legal form of M10C?
- M10C is a private limited company (BV).
- When was M10C founded?
- M10C was founded on 29-12-2014.
- Is M10C still active?
- Yes, M10C is an active enterprise in the KBO register.
- What is the turnover of M10C?
- The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €44,097 and 34 comparable companies (NACE 869). It probably lies between €100,000 and €190,000.Financials
- Is M10C profitable?
- In financial year 2025, M10C made a profit of €32,554.
- Where can I find the annual accounts of M10C?
- M10C filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of M10C due?
- M10C must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.